Delivery Order SPE2DB22D2211-SPE2DB24FMCN6

Award Date 11/7/23
Potential Completion Date 11/8/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $1,323.73 and a completion date of December 11, 2023. It is a firm-fixed-price delivery order contract, awarded on December 8, 2022. The contract is not...
This federal contract award is for the delivery of icosapent ethyl 1 gram capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,043.91, is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a cardiovascular medication, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,608.17, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of May 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...
This federal contract award is for the delivery of 120-count capsules of Icosapent Ethyl 1 gram, a specialty pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price, valued at $3,525.27, and has an ultimate completion date of October 27, 2022. The contract is not designated as a set-aside award, indicating it was competed in an open...
This federal contract award, valued at $1,248.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) for the supply of Icosapent Ethyl 1 gram capsules. The contract is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which runs through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,115.61 firm fixed price delivery order is for the supply of 120-count bottles of the pharmaceutical product Icosapent Ethyl 1 gram capsules. The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corporation with DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.70 delivery order covers the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, with a completion date of February 22, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.92 Firm Fixed Price Delivery Order is for the supply of Icosapent Ethyl 1 gram capsules, a prescription medication, with a period of performance through August 16, 2024. The award is not associated with a set-aside program. As a significant federal contractor, Amerisourcebergen provides a wide range of pharmaceutical products and medical...
This contract award, valued at $1,886.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of icosapent ethyl 1 gram capsules, a cardiovascular medication, in quantities of 120 capsules per bottle. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. The award is not designated as a set-aside contract. AmerisourceBergen...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FMCN6
    Delivery Order

This federal contract award is for the delivery of 120 count 1 gram capsules of Icosapent Ethyl, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,132.46, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2023. The contract has a final completion date of November 8, 2023 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award appears to be one of the many delivery orders placed under that larger IDC vehicle.

Generated 5/12/25, 9:50 AM